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Comparative Study of the
Antimicrobial Activity of Selenium
Nanoparticles With Different Surface
Chemistry and Structure.
Front. Bioeng. Biotechnol. 8:624621.
doi: 10.3389/fbioe.2020.624621
Comparative Study of the
Antimicrobial Activity of Selenium
Nanoparticles With Different Surface
Chemistry and Structure
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Although selenium nanoparticles (SeNPs) have gained attention in the scientific
community mostly through investigation of their anticancer activity, a great potential
of this nanomaterial was recognized recently regarding its antimicrobial activity. The
particle form, size, and surface chemistry have been recognized as crucial parameters
determining the interaction of nanomaterials with biological entities. Furthermore,
considering a narrow boundary between beneficial and toxic effects for selenium per se,
it is clear that investigations of biomedical applications of SeNPs are very demanding and
must be done with great precautions. The goal of this work is to evaluate the effects of
SeNPs surface chemistry and structure on antimicrobial activity against several common
bacterial strains, including Staphylococcus aureus (ATCC 6538), Enterococcus faecalis
(ATCC 29212), Bacillus subtilis (ATCC 6633), and Kocuria rhizophila (ATCC 9341), as well
as Escherichia coli (ATCC 8739), Salmonella Abony (NCTC 6017), Klebsiella pneumoniae
(NCIMB 9111) and Pseudomonas aeruginosa (ATCC 9027), and the standard yeast
strain Candida albicans (ATCC 10231). Three types of SeNPs were synthesized by
chemical reduction approach using different stabilizers and reducing agents: (i) bovine
serum albumin (BSA) + ascorbic acid, (ii) chitosan + ascorbic acid, and (iii) with glucose.
A thorough physicochemical characterization of the obtained SeNPs was performed
to determine the effects of varying synthesis parameters on their morphology, size,
structure, and surface chemistry. All SeNPs were amorphous, with spherical morphology
and size in the range 70–300 nm. However, the SeNPs obtained under different synthesis
conditions, i.e. by using different stabilizers as well as reducing agents, exhibited different
antimicrobial activity as well as cytotoxicity which are crucial for their applications. In
this paper, the antimicrobial screening of the selected systems is presented, which
was determined by the broth microdilution method, and inhibitory influence on the
production of monomicrobial and dual-species biofilm was evaluated. The potential
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mechanism of action of different systems is proposed. Additionally, the cytotoxicity of
SeNPs was examined on the MRC-5 cell line, in the same concentration interval as for
antimicrobial testing. It was shown that formulation SeNPs-BSA expressed a significantly
lower cytotoxic effect than the other two formulations.
Keywords: selenium nanoparticles (SeNPs), nanocomposites, antimicrobial activity, inhibition of biofilms, dual-
species biofilm
INTRODUCTION
The emergence of nanotechnology on the scientific scene greatly
expanded the application potential for numerous materials.
Thanks to the fact that materials with nanometer dimensions
exhibit properties different from bulk material, some of them
have found a completely new application field. Elemental
selenium is one of those materials. Nowadays, selenium is
well-known as an essential micronutrient of fundamental
importance to human and animal health (Rayman, 2000).
As the 21st amino acid, seleno-cysteine is a constituent of
many selenoproteins including glutathione peroxidases (GPx)
and thioredoxin reductase (TrxR). These enzymes are of great
significance in antioxidant processes. In addition, selenium
is recognized as a good candidate for cancer therapy and
prevention, as an anti-inflammatory agent, for treatment of
cardiovascular diseases and thyroidal disorders, and to be
actively engaged in bone and muscle metabolism (Clark,
1996; Ip, 1998; Rayman, 2000; Moreno-Reyes et al., 2001;
Zeng and Combs, 2008; Fernandes and Gandin, 2015). It
is necessary to emphasize that the biological activity of Se
depends on its chemical form and structure. For example,
elemental selenium is insoluble and for a long time had
been considered biologically inert. Consequently, in the past,
dominant selenium forms used in biomedical investigations were
selenomethionine (SeMet), selenocysteine, methylselenocysteine,
and sodium selenite. Nevertheless, with nanoscience expansion,
elemental selenium nanoparticles (SeNPs) emerged as a new
selenium form, which offered some advantages in comparison
with other selenium formulations. In several works, it was shown
that SeNPs provides a reduced risk of selenium toxicity, but
the same bioavailability and efficacy in increasing the activities
of selenoenzimes compared with Se-Met and selenite (Zhang
et al., 2001, 2008; Wang et al., 2007). These findings encourage
many authors to primarily investigate the anticancer activity of
SeNPs, bare or conjugated with other anticancer agents (Zhang
et al., 2013; Xia et al., 2015; Maiyo and Singh, 2017; Khurana
et al., 2019). One of the pioneering work that reported the
antimicrobial activity of SeNPs was done by Webster and Tran
(2011). In this paper, the authors demonstrated that SeNPs with
a diameter of around 100 nm significantly inhibit the growth of
Staphylococcus aureus at a concentration as low as 7.8µg/mL. In
the following years, interest in the antimicrobial activity of SeNPs
increased gradually among scientists, although this selenium
form was not such efficient in killing bacteria as metallic and
metal oxide nanoparticles (Ag, ZnO, and CuO). This interest
was supported by the facts that selenium represents an essential
micronutrient with diverse beneficial effects and that nanosized
selenium broadened the window of its safe usage. An especially
interesting field of research regarding the antimicrobial activity
of SeNPs, which recently gained attention, is the inhibition of
biofilm formation and activity against resistant microbial strains
(Wang and Webster, 2013; Shakibaie et al., 2015a; Guisbiers
et al., 2017; Prateeksha Singh et al., 2017; Cremonini et al.,
2018; Tran et al., 2019). Bacterial biofilm is considered as the
ultimate level of bacteria strategy in dealing with the immune
system and antibiotics. Polymicrobial biofilms even enhanced
this resistance due to the microbial synergy and therefore
increased the risk of serious health complications (Carolus et al.,
2019). Very often, polymicrobial infections originate from a
mixture of bacteria and fungi. A significant amount of these
infections, including those of C. albicans and Staphylococcus
species, are often associated with high mortality rates (Feng
et al., 2014). C. albicans and Staphylococcus species were co-
isolated from various biofilm-associated diseases, including
periodontitis, cystic fibrosis, denture stomatitis, urinary tract,
burn wound infections, and infections of medical devices such
as central venous catheters (Adam et al., 2002; Gupta et al., 2005;
Valenza et al., 2008; Cuesta et al., 2010). Various biofilm-specific
mechanisms of C. albicans provide additional protection to S.
aureus against antimicrobial agents and host immune responses
(Kong et al., 2016; Vila et al., 2019). For example, vancomycin
tolerance, mediated by β-1,3-glucans, may be increased by more
than 1000-fold (Harriott and Noverr, 2009). On the other hand,
S. aureus contributes to C. albicans immune resistance, as
well as tolerance toward antifungal agents such as miconazole
(Carolus et al., 2019). Due to the complex nature of polymicrobial
infections, finding their efficient treatment is very challenging
(Koo et al., 2017). According to our knowledge, the activity of
SeNPs against dual-species biofilms has not been reported so far.
In this framework, the present work aims to examine the
effects of surface chemistry on the antimicrobial activity of three
different SeNPs formulations. Accordingly, two of them were
prepared by variation of stabilizing agents (BSA or chitosan)
while using the same reductant, ascorbic acid. The third type
was synthesized, only by reduction with glucose. Although widely
accepted as just a reducing agent, glucose might also act as a
stabilizing agent (Liu et al., 2006). For instance, it is known that
β-D-glucose can easily both reduce and stabilize NPs by adjusting
the pH environment in an aqueous medium.
All SeNPs formulations were further used for antimicrobial
testing on four Gram-positive bacteria (S. aureus, Enterococcus
faecalis, Bacillus subtilis, and Kocuria rhizophila) as well on
four Gram-negative bacteria (Escherichia coli, Salmonella Abony,
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Klebsiella pneumoniae, and Pseudomonas aeruginosa), and on the
standard yeast strain Candida albicans. Based on obtained results
regarding antimicrobial activity, physicochemical properties, and
cytotoxicity, one formulation of SeNPs was selected for the
investigation of antibiofilm activity on monomicrobial and dual-
species biofilms. For this purpose, several clinical isolates of S.
aureus and C. albicans were used.
MATERIALS AND METHODS
Materials
All reagents used in synthesis and for other experimental
procedures were analytical grade. Sodium selenite, BSA, and
chitosan (mediummolecular weight) were purchased from Sigma
Aldrich, while ascorbic acid and glucose were obtained from
BDH Prolabo and Zorka Pharma, respectively. Double distilled
water was used for the preparation of solutions during the
synthesis procedure.
Synthesis of SeNPs
SeNPs were synthesized by a chemical reduction approach. The
experiments were planned byDOEmethodology, and parameters
were optimized concerning the high SeNPs yielding percent
and without compromising the particle size, morphology, and
amorphous nature. Three different formulations were obtained
by combining different stabilizing and reducing agents: (i) SeNPs
stabilized with BSA (SeNPs-BSA); (ii) SeNPs stabilized with
chitosan (SeNPs-Chit); and (iii) SeNPs synthesized only by
reduction with glucose (SeNPs-Gluc). Sodium selenite was used
as a precursor for all samples. The SeNPs-BSA and SeNPs-
Chit were obtained by reduction with ascorbic acid. Briefly,
sodium selenite was dissolved in distilled water at a concentration
of 0.02M (12.5mL). In separate flasks, 0.125M solutions of
ascorbic acid were prepared (10mL). These solutions were then
mixed with solutions of chitosan or BSA (5mL at concentration
0.87% w/w). In the final step, the prepared solution of sodium
selenite was added dropwise. Reaction mixtures were stirred on
a magnetic stirrer (1,500 rpm) until their colors change to red-
orange. The mass ratio between sodium selenite and chitosan or
BSA was adjusted to 1:1. For the third formulation (SeNPs-Gluc),
glucose was firstly dissolved in distilled water at a concentration
of 0.055M (25mL). This solution was then placed on a magnetic
stirrer, heated up to 130◦C, and stirred at 1,500 rpm. The 0.017M
solution of sodium selenite (10mL) was introduced drop by
drop immediately after heating started. After ∼1 h, the solution
became orange/reddish, as a sign of complete reduction and
conversion to Se0 nanoparticles. During the preparation of all
samples, reaction vessels were covered with aluminum foil to
prevent photo-oxidation and crystallization of obtained SeNPs.
After preparation, colloidal solutions of SeNPs were stocked at 4–
8◦C. For FTIR and XRDmeasurements, samples were lyophilized
in alpha 1-4 LD freeze dryer (Martin Christ) at 0.36 mbar.
FTIR Spectroscopy
The qualitative analysis of the samples was performed by FTIR
spectroscopy. The FTIR spectra were recorded on spectrometer
Nicolet iS10 (Thermo Fisher Scientific, Waltham, MA, USA),
using attenuated total reflectance (ATR) mode. Measurements
were performed in a spectral range of 400–4,000 cm−1 with a
resolution of 4 cm−1 and the number of scans was 32.
X-Ray Diffraction (XRD)
X-ray diffraction spectra were obtained on an X-ray
diffractometer, Philips PW 1,050 diffractometer with Cu-
Kα radiation (Ni filter). The samples were scanned in the 2θ
range of 10◦ to 60◦, with a scanning step width of 0.05◦, and 2 s
per step.
Morphology Investigation
The morphology of as-synthesized SeNPs was analyzed by
FESEM (Auriga Base, Carl Zeiss). For SEM analysis, the droplets
of samples were placed on aluminum tape and dried at room
temperature. Dried samples were then coated with gold using a
Sputter Coater (Q150T, Quorum Technologies).
Diffracted Light Scattering and Zeta
Potential
The Zeta-potential of as-synthesized SeNPs was measured using
a Zetasizer Nano ZS (Malvern Instruments, UK) instrument with
a 4 mW HeNe laser (633 nm) and a light scattering detector
positioned at 90◦. The hydrodynamic particle sizes of samples
were determined by dynamic light scattering (DLS, Zetasizer
Nano ZS) analysis at 25◦C, setting a minimum of 10 and a
maximum of 100 runs per measurement. For the measurements,
the as-synthesized SeNPs were used without dilution. The
analyses were performed in triplicate.
Quantitative Determination of Se
A Thermo Scientific iCap 6500 Duo instrument was used for
the determination of Se concentration in obtained samples.
Working solutions of selenium were produced by appropriate
dilutions of the corresponding stock solutions with 2.5% nitric
acid (HNO3). Working standards were prepared from the multi-
element standard solution, MES-21-1 (AccuStandrad, USA) in
the following concentrations: 10 ppb, 20 ppb, 50 ppb, 100 ppb,
0.2 ppm, 0.5 ppm, 1 ppm, and 2 ppm.
Antimicrobial Activity
Minimum inhibitory concentrations (MICs) of SeNPs-BSA,
SeNPs-Chit, SeNPs-Gluc, and Na2SeO3 against standard
microbial strains, were determined by the broth microdilution
method (CLSI, 2017). Each sample was diluted with microbial
growth media to final concentrations ranging from 400 to
12.5µg/mL and transferred into 96-well polystyrene microtiter
plates (Sarstedt, Germany). The wells were further supplemented
with bacterial suspensions (∼106 colony-forming unit per mL–
CFU/mL), as well as C. albicans suspension (∼107 CFU/mL),
and incubated for 24 h at 35◦C. Mueller-Hinton broth (MHB;
HiMedia, India) and Sabouraud Dextrose Broth (SDB; Torlak,
Serbia) were used as growth media for bacteria and yeast,
respectively. MICs were determined as the lowest concentrations
in which there was no visible growth of microorganisms.
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Morphology Observation by Optical
Microscopy
Optical microscopy was used for examination of the impact
of SeNPs treatment on the morphology and growth of the
pathogens. For this purpose, Gram-stained smears were prepared
from mixed S. aureus and C. albicans cultures in Trypton Soy
Broth (Torlak, Serbia) supplemented with an additional 1%
(w/v) glucose (TSBG) supplemented with SeNPs-BSA, SeNPs-
Chit, or SeNPs-Gluc, at 6.4µg/mL. In addition, control was
prepared without the addition of any Se formulation. The
images were taken from OPTICA B-500MET light microscope
(Optica SRL, Italy). Images were collected with OPTIKAM
PRO 8LT−4083.18 camera equipped with a scientific-grade
CCD sensor.
Antibiofilm Activity
The ability of SeNPs-BSA to inhibit biofilm production of S.
aureus and C. albicans was evaluated by the method described
by Stepanović et al. (2007). Both, type strains (S. aureus ATCC
6538 and C. albicans ATCC 10231) and clinical isolates were
included in this experiment (Supplementary Table 1). TSBGwas
used as a growth medium for both bacteria and yeasts. According
to the Clinical and Laboratory Standards Institute antimicrobial
susceptibility testing standards, MHB is a preferred medium for
the broth-microdilution method (CLSI, 2017). When it comes
to the biofilm assay, Stepanović et al. recommend TSBG as
the most suitable medium for staphylococcal biofilm cultivation
(Stepanović et al., 2007). Scaffaro et al. also used this medium
for the cultivation of dual-species biofilms produced by S. aureus
and C. albicans (Scaffaro et al., 2018). SeNPs-BSA were added to
96-well polystyrene microtiter plates at concentrations ranging
from 6.4 to 1.6µg/mL, while TSBG supplemented with an equal
concentration of BSA was used as a positive control. Previously
we have tested a wider spectrum of concentrations against
differentmicroorganisms, and based on the obtained results (data
not presented), it was determined that concentrations higher
than 6.4 ug/ml were notmore effective in the inhibition of biofilm
production. The incubation of the strains (∼106 CFU/mL) was
carried out at 35◦C for 24 h. Planktonic cells were then washed off
with Phosphate-Buffered Saline (PBS; pH 7.2), and the remaining
surface-bound biofilm was fixed by air-drying at 60◦C for 1 h and
stained with 0.5% safranin (HiMedia, India) for 15min. Finally,
the stain was extracted with 96% (v/v) ethanol and its optical
density (OD) was measured at 492 nm by using EZ Read 400
ELISA reader (Biochrom, USA).
Dual-Species Biofilm Inhibitory Activity
Dual-species biofilm production of treated combinations of S.
aureus and C. albicans strains was evaluated on polystyrene
surface of 96-well microtiter plates, as well as on radiopaque
polyurethane surface of Two-Lumen Central Venous Catheter
(CVC; Arrow International, USA). In both cases, thematerial was
firstly seeded with C. albicans (∼106 CFU/mL) and incubated for
1 h at 35◦C to allow the yeast-to-hyphae transition. Afterward,
S. aureus (∼106 CFU/mL) was added, putatively binding to
previously formed C. albicans hyphae, and incubated for an
additional 24 h at 35◦C (Scaffaro et al., 2018). Vein-indwelling
tube of CVC was cut into small pieces, which were then scrubbed
with water and soap, rinsed with hot tap water and distilled water,
three times each, and finally autoclaved at 121◦C for 15min.
Washing, fixation, and staining procedures were performed as
described above. Evaluation of biofilm production on CVC was
performed using the modified biofilm index, based on digital
image analysis for color brightness quantification, as described
by Yamamoto et al. (2007).
In addition, the colony counting method was employed to
determine the relative numbers of microorganisms in mixed
biofilms. Briefly, dual-species biofilms composed of treated S.
aureus ATCC 6538 and C. albicans 10231, formed as described
above in polyethylene tubes, were washed three times with PBS,
and the remaining biofilm cells were resuspended in 3mL of PBS
with vigorous vortexing for 1.5min. Serial 10-fold dilutions were
prepared and plated on mannitol salt agar (MSA; Torlak, Serbia)
and Sabouraud dextrose agar (SDA; Torlak, Serbia) to count the
colonies of S. aureus and C. albicans, respectively, following the
incubation for 24 h at 37◦C.
Reduction of Dual-Species Biofilm Cell
Viability
The viability of dual-species biofilm cells, following the treatment
with SeNPs-BSA, was estimated by using 2,3,5-triphenyl-2H-
tetrazolium chloride (TTC; Sigma-Aldrich, USA) (Sabaeifard
et al., 2014). After the overnight incubation, the plates were filled
with 120 µL of fresh TSBG and 30 µL of 0.5% (w/v) TTC,
immediately after the washing procedure, skipping the air-drying
fixation step and incubated for another 6 h at 35◦C. ODs were
measured at 405 nm.
Statistical Analysis
Each test was repeated three times. Results are presented as
mean values ± standard deviations (SDs). All the groups were
confirmed to exhibit normal distribution by the Shapiro–Wilk
test. Experimental and control groups were compared by one-
way analysis of variance (ANOVA), followed by Tukey’s post hoc
test. Calculations were performed using the SPSS Statistics, IBM
SPSS Software, v24.0 (IBM, USA).
Cytotoxicity of SeNPs
MRC-5 cells were cultured in Dulbecco’s modified Eagle medium
supplemented with 10% FBS and 1% penicillin/streptomycin
mix, at 37◦C in 5% CO2 and high humidity. Cells were split upon
reaching confluency.
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) assay was used to assess cytotoxicity of SeNPs. Cells
were seeded at a density of 2× 104 cells/well in 96-well plates and
incubated for 24 h at 37◦C in 5% CO2 before SeNPs treatment.
Then, the medium was discarded and 200 µl/well of fresh
medium containing different concentrations of SeNPs samples
(SeNPs-Gluc, SeNPs-Chit, SeNPs-BSA) was added to the wells.
After 24 h of incubation at 37◦C in 5% CO2, the treatment
medium was replaced with fresh medium, followed by the
addition of 20 µl/well of 5 mg/ml MTT solution. After 4 h of
incubation, the medium was carefully discarded and formazan
crystals dissolved using 200 µl/well of DMSO. Absorbance
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was recorded at 570 nm. Results are expressed relative to the
absorbance of control cells.
RESULTS AND DISCUSSION
Synthesis of SeNPs
Several different techniques have been employed in SeNPs
synthesis, so far. These techniques can be roughly classified
into three groups: chemical reduction methods, conversion
by physical field (microwave-assisted or laser ablation), and
biosynthesis approach. All of them offer some advantages and
drawbacks and the majority can be found in the following review
papers (Chaudhary et al., 2014, 2016; Wadhwani et al., 2016;
Hosnedlova et al., 2018; Sakr et al., 2018; Shi et al., 2020).
Chemical reduction methods are simple, economical, fast, and
suitable for production on a larger scale. The choice of reducing
and stabilizing agents as well as their concentrations are crucial
from the point of particle size and morphology. In our previous
work (Stevanović et al., 2015) we have already determined the
optimal ratio between ascorbic acid and sodium selenite, which
was also confirmed in a paper, recently published by Chung et al.
(2020). BSA and chitosan are selected as models of stabilizing
agents since they represent different types of macromolecules.
Albumins are generally the most abundant globular proteins
in serum and provide good biocompatibility while chitosan is
a cationic, linear polysaccharide with documented antibacterial
properties. Their application in the stabilization of SeNPs was
already reported in many papers (Valueva et al., 2007; Chen et al.,
2015; Lara et al., 2018; Filipović et al., 2019; Chung et al., 2020; Shi
et al., 2020). The third formulation of SeNPs is designed to obtain
nanoparticles without using any macromolecule as a stabilizing
agent while not compromising parameters such as crystallinity,
size, and morphology.
FTIR Characterization
As it was expected for lyophilized samples, the dominant
absorption of the IR incident beam from the O-H bond is
recorded around 3,300 cm−1 (Figure 1). Besides this, several
peaks can be noticed in all spectra: vibrations of C-O and C-
C bonds around 1,050 cm−1, C-H bending vibrations around
1,350 cm−1, and peak at ∼1,580 cm−1 that is much more
pronounced in spectra of SeNPs-BSA and SeNPs-Chit. The first
two peaks originate from functional groups dominant in the
structure of ascorbic acid, glucose, and chitosan (Ibrahim et al.,
2006; Bunaciu et al., 2009; Kumirska et al., 2010). If we considered
the third peak from the aspect of composition, there is no clear
analogy of its origin. Both BSA and chitosan belong to complex
macromolecules which among others, exhibit characteristic
amide I band at ∼1,650 cm−1, amide II band at ∼1,550 cm−1,
and amide III band at ∼1,250 cm−1 (Grdadolnik and Maréchal,
2001; Kumirska et al., 2010). Additionally, ascorbic acid displays
a strong band around 1,650 cm−1 due to the C-O stretching
vibrations. Nevertheless, in spectra of SeNPs obtained with these
two stabilizers, only one peak appears at 1,580 cm−1. Since
amide I and II bands originate from vibrations of C=O and
N-H bonds and reflect the secondary structure of mentioned
macromolecules, it is possible that during the synthesis procedure
FIGURE 1 | FTIR spectra of different SeNPs formulations and commercial
compounds used in the synthesis procedures.
those structures are changed as a consequence of the adsorption
on the surface of SeNPs, preventing them from agglomeration in
a larger scale.
XRD Characterization
To evaluate the crystalline nature of obtained SeNPs, lyophilized
samples were characterized by the XRD technique. The
obtained diffractograms are given in Figure 2. Based on these
diffractograms it can be seen that all samples exhibit short-range
arrangement i.e., amorphous structure. In amorphous materials
incident X-rays are scattered in many directions leading to a
constant oscillation of signal line distributed in a whole range
of 2θ instead of high intensity narrower peaks. These diffraction
peaks as proof of the crystalline phase were not recorded. For
comparison reason, the diffractogram of elemental Se is given
in Figure 2. This sample was prepared by the same procedure
as SeNPs-BSA and SeNPs-Chit but without employing any
stabilizing agents. Several narrow peaks noticed for this sample
point to its crystalline nature. All the peaks could be indexed
according to the trigonal phase of elemental selenium (Shah
et al., 2010). Since the trigonal form of Se is thermodynamically
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FIGURE 2 | XRD patterns of different SeNPs formulations.
most stable, obtaining amorphous SeNPs can be challenging in
procedures that involve elevated temperature. For example, some
authors reported obtaining SeNPs with the crystalline structure
in similar conditions such were used in the SeNPs-Gluc synthesis
(Ingole et al., 2010; Koo et al., 2017). In addition, Zhang and
others reported that heating of colloidal solution of amorphous
SeNPs at 90◦C caused the transformation to trigonal form (Zhang
et al., 2012). Pinto et al. even shown that this transformation
is even possible as a spontaneous process at room temperature
during the time (Pinto et al., 2012). The crystallinity of SeNPs
was proven as an important factor for its bioavailability and
bioactivity (Zhang et al., 2012). Thus, to perform an adequate
comparison of antimicrobial activity between samples, all of them
needed to be amorphous.
Morphological Characterization
The morphology of nanoparticles is one of the three parameters
that have the most significant influence on their interaction
with biological entities. Results obtained from scanning electron
microscopy of SeNPs are represented in Figure 3. The sample of
SeNPs-Gluc possesses spherical morphology with a particle size
of around 100–200 nm. When it comes to the other two samples,
micrographs imply the agglomeration of particles at a higher
level. This agglomeration could be attributed to the evaporation
FIGURE 3 | FE-SEM micrographs of different SeNPs formulations.
(A,B) SeNPs-BSA, (C,D) SeNPs-Chit, (E,F) SeNPs-Gluc.
process, adhesive properties of stabilizers, degradation of the
surface coating of the NPs since the stability of the chitosan
is very often influenced by environmental conditions such as
the lyophilization process. All these processes led to significant
alterations of the morphology and properties of biomolecules-
based coatings that further affect agglomeration. Nevertheless,
the size of the individual particles can be estimated to be lower
than in the case of SeNPs-Gluc, around 100 nm. Inmany previous
works, the chemical reduction approach proved to be convenient
for producing spherical and amorphous SeNPs (Hosnedlova
et al., 2018; Sakr et al., 2018; Shi et al., 2020). Among other
parameters (concentrations, the ratio between dispersion phases,
mixing method, temperature, etc.), final morphology strongly
depends on the choice of stabilizers. Spherical particles are most
frequent since this morphology provides a lower level of surface
energy. As it was stated earlier, one of the goals in this work was to
compare SeNPs with the same morphology and with comparable
size but with different surface chemistry.
The Size Distribution and the Stability of
Nanoparticle Suspensions
DLS (Figure 4) and measurements of zeta potential (ZP)
(Table 1) were conducted to gain insight into the parameters
of SeNPs colloidal solutions. The ZP value is a very important
parameter for the evaluation of the stability of nanoparticle
suspensions (Honary and Zahir, 2013). When nanoparticles
are stabilized with low molecular weight surfactants, mainly
through electrostatic interactions, it is considered that ZP values
higher than 25mV point to very good stability (Shnoudeh
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FIGURE 4 | The size distribution of different SeNPs formulations, measured by
diffracted light scattering.
TABLE 1 | Values of zeta potential and average hydrodynamic radius for different
SeNPs.
Measurements\Formulations SeNPs-BSA SeNPs-Chit SeNPs-Gluc
Mean Zeta potential (mV) +27 ± 3 +24 ± 1 −45 ± 1
Average hydrodynamic radius (nm) 76 ± 2 162 ± 3 199 ± 5
et al., 2019). However, when stabilization is achieved with high
molecular weight stabilizers (steric stabilization) ZP values of
only 20mV or lower can provide sufficient repulsive forces and
good stabilization (Honary and Zahir, 2013). The values of zeta
potential, obtained from three measurements for each SeNPs
formulation, are given in Table 1.
Based on the presented results it is expected that all samples
possess good stability. Absolute values of zeta potential increases
in order: SeNPs-Chit<SeNPs-BSA<SeNPs-Gluc While BSA
and chitosan provide a positive charge of SeNPs surface, the
formulation obtained by reduction with glucose exhibit a highly
negative charge. These results confirmed that SeNPs are well
covered/stabilized with both BSA and chitosan, providing free
amino groups and net positive charge. The negative surface
charge of particles prepared without stabilizing agents was also
reported in two separate papers, for particles prepared with
pulsed laser ablation (Guisbiers et al., 2016; Geoffrion et al.,
FIGURE 5 | Macroscopic observation of SeNPs stability.
2020). The highest value obtained for suspension of SeNPs-Gluc
indicates that this suspension is the most stable. However, results
obtained from particle size distribution and scanning electron
microscopy revealed that some amount of the particles in this
sample have a diameter above 200 nm, which increases the risk
of particles sedimentation (Frens, 1972; Larsson et al., 2011). The
size distribution of formulation prepared with chitosan indicates
a bimodal distribution and the presence of a small fragment
of significantly larger particles, over 1 micron. Considering the
FESEM image of this sample, the formation of big agglomerates
is most likely the reason for this wide distribution. The narrowest
particle size distribution, as well as the smallest diameter
(<100 nm), were observed in the formulation SeNPs-BSA. The
values of the mean hydrodynamic radius obtained for all SeNPs
formulations are listed in Table 1.
Further investigation of the stability of obtained colloidal
solutions of SeNPs was conducted by visual observation
for 2 months. The macroscopic observation of samples
stability after 1 day and 2 months is given in Figure 5.
As it can be seen, only sample SeNPs-BSA remained stable
without the occurrence of turbidity or precipitation which is
the case for SeNPs-Chit and SeNPs-Gluc, respectively. This
result is in good agreement with those obtained from the
DLS measurements. The stability of nanoparticle systems is
important from the aspect of the application, particularly
interaction with biological entities. The unstable systems are
not reliable since their interaction can be easily changed upon
particles agglomeration.
Quantitative Analysis of Se in Obtained
SeNPs Formulations
The quantitative determination of SeNPs in obtained colloidal
solutions was performed by ICP-AES analysis and the following
results were obtained: 624µg/mL for SeNPs-BSA, 610µg/mL
for SeNPs-Chit, and 428µg/mL for SeNPs-Gluc. These
concentrations represent more than 90% of the theoretical yield.
Considered from the composition of the nanoparticles and by
the assumption that all stabilizing agents are well attached on the
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TABLE 2 | MIC values (µg/mL) of different SeNPs formulations and sodium selenite against standard microbial strains.
Microorganism type Strain SeNPs-BSA SeNPs-Chit SeNPs-Gluc Na2SeO3
Gram-positive bacteria Staphylococcus aureus ATCC 6538 100 100 290 100
Enterococcus faecalis ATCC 29212 100 100 290 >400
Bacillus subtilis ATCC 6633 200 100 290 >400
Kocuria rhizophila ATCC 9341 200 100 145 200
Gram-negative bacteria Escherichia coli ATCC 8739 400 200 290 >400
Salmonella Abony NCTC 6017 400 400 >400 >400
Klebsiella pneumoniae NCIMB 9111 200 200 290 >400
Pseudomonas aeruginosa ATCC 9027 400 400 >400 >400
Fungi Candida albicans ATCC 10231 25 25 72 400
The bold values represent the most significant antimicrobial effect.
surface of Se, it could be estimated that concentrations of pure Se
in SeNPs are 290 and 280µg/mg for SeNPs-BSA and SeNPs-Chit,
respectively. The confirmation of complete reduction of sodium
selenite can be also found in the diffraction pattern of obtained
lyophilized samples since none of the reflection, characteristic
for this compound, was noticed (Youngren et al., 2013).
Additionally, in FTIR spectra of all SeNPs formulations, the
presence of a strong peak at 715 cm−1 was not detected, as in the
case of commercial sodium selenite (Supplementary Figure 1).
This intensive peak could be attributed to the vibrations of the
Se-O bond.
Antibacterial and Antifungal Activities of
SeNPs
The ability of three different formulations of SeNPs to inhibit
the growth of four Gram-positive and four Gram-negative
common bacteria, as well as of yeast C. albicans, was investigated.
As indicated in Table 2, SeNPs were most active against C.
albicans, particularly, SeNPs-BSA and SeNPs-Chit yielded MICs
as low as 25µg/mL while SeNPs-Gluc induces the same effect
at concentration 72µg/mL (MIC concentrations presented in
Table 2 refer to the concentrations of pure Se). In previous works,
the activity of biogenic SeNPs, synthesized with Bacillus sp.Msh-
1 (80–220 nm), was tested against C. albicans. Obtained MICs
varied between 70 and 100µg/mL and the authors described
their results as good antifungal activity (Shakibaie et al., 2015b;
Parsamehr et al., 2017). Furthermore, the SeNPs formulations
presented in this work showed more potent activity against
Gram-positive species. This behavior could be attributed to a
significant difference in bacterial wall composition, including
abundant pores and a thin layer of peptidoglycan. Many authors
reported similar results so far (Guisbiers et al., 2015; Tran
et al., 2016). However, in the paper presented by E. Cremonini
et al. it was shown that biogenic selenium nanoparticles possess
very good antimicrobial activity against clinical isolates of P.
aeruginosa but lower efficacy toward C. albicans (Cremonini
et al., 2016). Interestingly, in the same study, the authors
compared the antimicrobial activity of biogenic and chemically
synthesized SeNPs and obtained significantly better results
for the first one. Since biosynthesized SeNPs have a special
biogenic surface coating, the authors suggest that this is the
reason for higher antimicrobial activity. Especially efficient
were the chitosan-stabilized SeNPs, which is in agreement with
observations that chitosan alone possesses potent activity against
Gram-positive species (Goy et al., 2009). Recently, Rangrazi et al.
tested the antimicrobial activity of chitosan-stabilized SeNPs
with a diameter range of 50–105 nm (Rangrazi et al., 2020).
They documented MICs of 137 and 274µg/mL against S. aureus
and E. faecalis, respectively, but did not observe any activity
against Gram-negative species. When it comes to Gram-negative
bacteria, K. pneumoniae was most susceptible to tested samples,
whereas the lowest activity was exhibited against S. Abony and P.
aeruginosa. Overall observed, formulation SeNPs-Gluc achieved
the lowest activity against all microbial strains except for K.
rhizophila and E. coli. For these bacteria, SeNPs-Gluc have
demonstrated activity at a lower concentration in comparison
with SeNPs-BSA.
All SeNPs formulations have expressed higher antimicrobial
activity than sodium selenite against all tested strains (Table 2).
This difference is most profound for C. albicans, E. faecalis,
and B. subtilis. Based on this observation, it could be concluded
that nanoparticle systems express activity through a different
mechanism of action.
The use of nanoparticles as antimicrobial agents is a promising
strategy, especially when dealing with chronic and nosocomial
infections. The widespread usage of commercial antibiotics has
led to the development of multidrug-resistant bacterial strains.
Generally, various mechanisms of nanoparticles antimicrobial
activity were recognized up to now: ROS generation, interaction
with cell barrier (cell wall disruption and alteration in
permeability), inhibition in the synthesis of proteins and DNA,
expression of metabolic genes, etc. (Hemeg, 2017; Wang et al.,
2017; Eleraky et al., 2020). When it comes to metal-based
nanoparticles, the antimicrobial activity is very often attributed
to ROS production (hydroxyl radicals, superoxide anions, and
hydrogen peroxide). These ROS species can further inhibit
DNA replication and amino acid synthesis as well as induce
damage to the bacterial cell membrane (Hemeg, 2017). From
the literature, the morphology of nanoparticles also plays the
important role in its effectiveness against microbial species
(Hong et al., 2016; Cheon et al., 2019). The main advantage
of nanoparticles as antimicrobial agents could be described
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as their ability to simultaneously act through these multiple
mechanisms. As a result, microbes are unable to develop
resistance to these expressed mechanisms of action, contrary to
commercial antibiotics.
Based on the literature data, a comparison of antimicrobial
activity of differently stabilized SeNPs, have not been investigated
in the past. However, a similar study was done regarding the
anticancer activity of SeNPs stabilized with different amino
acids. In this work, authors reported an increase in activity for
system “decorated” with positively charged amino acid-Lysine
in comparison with the other two systems where neutral and
anionic amino acids were used (Feng et al., 2014). It is also
interesting to consider the antimicrobial activity of different
SeNPs samples from the zeta potential aspect. In opposite to
the other two samples, SeNPs-Gluc possesses a highly negative
surface charge as is shown in Table 1. The overall antibacterial
activity of this sample is significantly lower than for the other
two samples. According to some authors, positively charged
NPs have greater potential in inhibition of bacterial growth
due to the better attachment on bacterial (Pan et al., 2013;
Fang et al., 2015). Conversely, negatively charged particles need
to overcome repulsive interaction to adhere to the bacteria’s
surface. Arakha et al. reported that high concentrations of
negatively charged NPs could induce significant antibacterial
activity due to the phenomenon known as molecular crowding
(Arakha et al., 2015). Here reported negatively charged SeNPs,
exhibit more pronounced activity toward Gram-positive bacteria,
which could be described by the lack of negatively charged LPS
molecules in their cell walls and consequently the absence of
mentioned electrostatic repulsions. If we consider that the same
behavior was also observed for positively charged formulations
of SeNPs, it could be concluded that electrostatic interaction
between SeNPs and bacterial cell barrier is not a crucial step
that determined their antimicrobial activity. Negatively charged
regions on the cell’s wall of Gram-negative bacteria are not
sufficient to ensure attachment of positively charged SeNPs. The
penetration channels in the cell wall of Gram-negative bacteria
are very small allowing the entrance to macromolecules only.
Furthermore, from the aspect of particle size, sample SeNPs-
BSA should be most active, since these particles possess a
smaller diameter. It is a known fact that the internalization of
nanoparticles increases with the decrease in their size. In the
work of Huang and coauthors, it has been reported that SeNPs
with a mean diameter of 80 nm exhibit the best antimicrobial
activity against methicillin-sensitive and methicillin-resistant S.
aureus (Huang et al., 2019). The investigated diameter range in
this study was from 40 to 200 nm, and polyvinyl alcohol (PVA)
was used as a stabilizer. In contrast to this finding, the best
overall antimicrobial activity was recorded for sample SeNPs-
Chit, which possesses the wider distribution and significantly
larger diameter than SeNPs-BSA. In the end, formulations
SeNPs-Chit and SeNPs-Gluc have more comparable size but
express remarkable different antimicrobial activity. Based on the
results that are presented here it can be concluded that surface
chemistry is the most influenced parameter that determines the
antibacterial activity of SeNPs. Subsequent to surface chemistry
is particle size, where further investigation must be done to
FIGURE 6 | Light microscopy images showing the impact of SeNPs
formulations on S. aureus and C. albicans: (A) control- prepared without the
addition of any SeNPs formulation, (B) SeNPs-BSA, (C) SeNPs-Chit, (D)
SeNPs-Gluc. Magnification bars 10µm.
precisely determine the thresholds for some mechanisms of
antibacterial activity.
Morphology Observation by Optical
Microscopy
The impact on the morphology and growth of the pathogens
S. aureus and C. albicans, after the treatment with SeNPs,
has been done by OPTICA B-500MET light microscope. It
is known that C.albicans can act synergistically with bacteria,
especially with S. aureus, which has a strong affinity for C.
albicans hyphae (Peters et al., 2010; Lin et al., 2013). It
has been suggested by Kean et al. that S. aureus can form
mycofilms, which is a new biofilm on already formed biofilm,
using C.albicans hyphae as scaffolds (Kean et al., 2017). This
interaction can greatly enhance virulence and resistance to
antimicrobials of both pathogens (Kean et al., 2017; Carolus
et al., 2019). Our results obtained by optical microscopy imply
a significantly decreased number of S. aureus cell clusters
attached to C. albicans hyphae after the treatment with all SeNPs
formulations (Figure 6).
Cytotoxicity of SeNPs
To closely confirm the application potential of SeNPs, their
effects on eukaryotic cells were investigated by MTT assay.
The obtained results are presented in Figure 7 (presented
concentrations refer to the concentrations of pure Se). A
surprisingly large difference in cell viability was observed after
their treatment with different formulations of SeNPs. SeNPs-
BSA showed minor cytotoxicity at the highest concentrations
(400 and 100µg/ml). Lower doses (20, 10, 1 and 0.1µg/ml) did
not show cytotoxic effect (cells survival rate was above 80%).
The dose of 100µg/ml of SeNPs-Chit was cytotoxic, but at
all lower concentrations, more than 80% of cells were viable.
At 400µg/ml, red-colored SeNPs could not be fully washed
from the cells, therefore absorbance of samples treated with this
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FIGURE 7 | MRC-5 cell viability after the treatment with different formulations of SeNPs. Results were presented as relative to the untreated cells. Controls on the right
side were prepared with appropriate amounts of BSA, chitosan, and glucose, as it was used in the synthesis of SeNPs.
concentration was not considered reliable. This effect was not
present at lower concentrations, indicating possible excessive
cellular uptake at high exposure of cells to SeNPs-Chit. SeNPs-
Gluc has expressed more profound cytotoxic effects at almost all
tested concentrations, except 1µg/ml. The partial contribution
of this phenomenon can be attributed to the fact that pure
glucose solution, used for the synthesis of SeNPs-Gluc showed
significant cytotoxicity compared to other controls. The other
possible explanation could be found in the particle size since both
SeNPs formulations with higher cytotoxicity rates possess larger
particles (Figure 7).
Considering results obtained from antimicrobial and
cytotoxicity testing as well as those regarding stability and size
distribution, further investigation of antibiofilm activity has
proceeded with formulation SeNPs-BSA.
Monomicrobial and Dual-Species Biofilm
Production Is Profoundly Inhibited by
SeNPs
A total of five strains of S. aureus and two strains of C. albicans
were assessed on monomicrobial biofilm production, following
the treatment with SeNPs-BSA. The significant dose-dependent
inhibitory activity (P < 0.05; P < 0.01; P < 0.001) of SeNPs-
BSA was observed in all tested strains (Figure 8). However,
different strains responded variously. While the greatest level
of suppression was noticed in C. albicans ATCC 10231 (93–
99%) and S. aureus BL254 (80–93%), the biofilm production was
the least affected in S. aureus BL251 (10–59%) and C. albicans
DM790 (26–61%). In overall, the concentration of 6.4µg/mL
provided significant inhibition (P < 0.01; P < 0.001) in all tested
strains, reducing the production by more than 50% (59–99%).
These results are in agreement with some previous findings. For
instance, in a study done by Shakibaie et al. biogenic SeNPs
(80–220 nm) were tested against several clinical isolates of S.
aureus and achieved a substantial level of inhibition at 2µg/mL
(41%) and 4µg/mL (58%) (Shakibaie et al., 2015a). However,
increasing the concentration to 16µg/mL did not lead to any
significant changes. Guisbers et al. have tested SeNPs synthesized
by pulsed laser ablation in liquids (50–400 nm) against the
biofilm production of C. albicans and observed dose-dependent
inhibition up to 50% when increasing the concentration to 27
ppm (Guisbiers et al., 2017). In addition, they noticed that the
smallest and crystalline SeNPs are the most active ones.
The biofilm structure provides various additional resistance
and tolerance mechanisms to microorganisms, therefore,
affecting its production could enhance the activity of
antimicrobials and the host immune system, and subsequently
stimulate the eradication of pathogens such as S. aureus and
C. albicans (Koo et al., 2017). Most of the research articles
deal with monomicrobial biofilm production, however, having
in mind the clinical significance of S. aureus and C. albicans
dual-species biofilm, and the additional tolerance and resistance
mechanisms that this entity is equipped with, we decided to
assess the activity of SeNPs-BSA against this type of biofilm, as
well. The results revealed severe suppression of S. aureus ATCC
6538/C. albicans ATCC 10231 dual-species biofilm production
(78–93%; P < 0.001), with significant dose-dependent effect (P
< 0.01; P < 0.001) (Figure 8). Interestingly, the dual-species
biofilm production was less affected by tested nanoparticles
in communities of S. aureus and C. albicans DM790. Perhaps
this clinical strain of C. albicans provides better protection
to S. aureus, in comparison to C. albicans ATCC 10231,
producing a denser biofilm matrix with more β-1,3-glucans,
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FIGURE 8 | The activity of SeNPs-BSA against monomicrobial and dual-species biofilm production represented as the percentage of biofilm production compared to
untreated control. *P < 0.05, **P < 0.01, ***P < 0.001.
FIGURE 9 | Biofilm cell viability of S. aureus ATCC 6538/C. albicans ATCC
10231 dual-species community after treatment with SeNPs-BSA. ***P <
0.001.
allowing the protected bacteria itself to produce more
biofilm. At the same time, this could explain why the biofilm
production of S. aureus was more inhibited when incubated
without C. albicans.
It should be noted that the antibiofilm activity of SeNPs-
BSA, presented in this study (Figure 8), was demonstrated by
using safranin that stains all biomass of the biofilm, including
live and dead cells, and the extracellular polymeric substances
(EPS), which may be overproduced by biofilm cells under
the stress conditions (Bay et al., 2017). For this reason, we
conducted an additional cell viability test (Figure 9), using TTC
to measure exclusively live biofilm cells, both culturable and
viable but non-culturable (VBNC) (Azeredo et al., 2017). Results
obtained from this test, conducted on S. aureus ATCC 6538/C.
albicans ATCC 10231 dual-species biofilm, revealed that the
quantity of live cells is significantly inhibited, as is the whole
biomass, ranging from 5.65- to 7.88-fold (P < 0.001), in a
dose-dependent mode.
When it comes to the relative numbers of each species in
this biofilm community, interestingly only the quantity of C.
albicans viable culturable biofilm cells was reduced by SeNPs-
BSA at all tested concentrations, most significantly at 6.4µg/mL
(P < 0.01) (Figure 10). The number of viable culturable biofilm
cells of S. aureus was decreased only when the biofilm was grown
in the presence of SeNPs-BSA at 6.4µg/mL (P < 0.05). The
reduction of viable cells was not as nearly severe as obtained
when using TTC cell viability assay. However, it should be noted
that TTC measures both culturable and non-culturable (VBNC–
viable but non-culturable) biofilm cells, so it could be assumed
that VBNC cells were more affected. This observation further
contributes to the significance of obtained results, considering
that VBNC cells provide the biofilms with an additional tolerance
to high doses of antibiotics and other extreme conditions
(Ayrapetyan et al., 2018).
The antimicrobial activity of nanoparticles against
polymicrobial biofilm was reported only in a few papers so
far. Su et al. recently reported inhibiting activity of chitosan
nanoparticles loaded with coumarin against S. aureus and C.
albicans monomicrobial and dual-species biofilm (Koo et al.,
2017). The authors found that the effective concentration range
for this system was 100–200µg/mL. In another work done by
H. Lara and J. Lopez-Ribot, AgNPs were able to inhibit the
growth of the same dual-species biofilm at a concentration of
2 ppm (Lara and Lopez-Ribot, 2020). Despite the considerable
interest in the use of AgNPs as an antimicrobial agent, there are
some limitations for the safe application of this material such as
cytotoxic effects and possible diminished therapeutic effects in
prolonged treatment (Kostenko et al., 2010; Gliga et al., 2014;
Kim, 2016).
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FIGURE 10 | Relative numbers of S. aureus and C. albicans in mixed biofilms grown in the presence of SeNPs-BSA represented as logarithms of colony-forming units
per milliliter [log(CFU/mL)]. *P < 0.05, **P < 0.01.
FIGURE 11 | S. aureus ATCC 6538/C. albicans ATCC 10231 dual-species biofilm production on two-lumen Central Venous Catheter (CVC) in the presence of
SeNPs-BSA. Coming from the left: digital image of CVC with a sampling region marked by arrow; digital image of tested CVC pieces; digital image used for color
brightness quantification-red/green/blue (RGB) splitting, logarithmic transformation of R and G images, and brightness correction; quantified biofilm index with *P <
0.05, **P < 0.01, ***P < 0.001.
Further, biofilm infections are frequently associated with the
use of indwelling medical devices. These types of infections
are particularly dangerous, difficult to treat, and in most cases
require complete removal of colonized devices or surgical
excision of the infected tissue (Xu et al., 2017). Catheter-
related bloodstream infections (CRBSIs) are common causes of
severe hospital-acquired infections. Yearly mortality rates have
been estimated at 7.7–23.1%. Besides, CVC is associated with
considerably higher risk compared to the peripheral venous
catheter (Saliba et al., 2018). Polymicrobial infections account
for 9% of CRBSIs, with S. aureus and C. albicans being two
of the most frequently isolated bacterial and fungal pathogens,
respectively (Harriott et al., 2016; Thorarinsdottir et al., 2020).
Therefore, we assessed the production of S. aureusATCC 6538/C.
albicans ATCC 10231 dual-species biofilms on radiopaque
polyurethane vein-indwelling surface of CVC in the presence of
SeNPs, as well. As can be seen from Figure 11, the experiment
was performed in triplicate and the pieces, which represented
positive control (at the bottom), were most abundant in reddish-
colored patches, each representing individual biofilm structure.
Significant dose-dependent reduction of biofilm production (P <
0.05; P < 0.01; P < 0.001) was revealed by using color brightness
quantification (Figure 11). According to this, the dual-species
biofilm was inhibited by 87 and 48%, when using SeNPs-BSA at
6.4 and 1.6µg/mL, respectively.
Bearing in mind results obtained for antibiofilm activity,
SeNPs-BSA can be considered as a promising candidate for
inhibition of biofilm production, both monomicrobial and
dual-species biofilm. This inhibition was observed in biofilms
derived from clinical isolates of S. aureus and C. albicans
and it was equally pronounced in real conditions i.e., surface
of CVC. Further investigation should be done to determine
the precise mechanism of biofilms inhibition by SeNPs and
to examine the effects of different substrates on SeNPs
antibiofilm activity.
CONCLUSIONS
The antimicrobial activity of nanoparticles is a growing research
field that demands a very complex evaluation strategy. When
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it comes to SeNPs diverse results have been reported so far. In
this work, we have successfully synthesized three formulations
of SeNPs using a simple, chemical reduction approach. Particles
were obtained in the form of colloidal solutions and within the
size range of 75–200 nm. The influence of surface chemistry
on antimicrobial activity was investigated on eight standard
bacterial strains and one yeast strain (S. aureus, E. faecalis, B.
subtilis, K. rhizophila, E. coli, S. Abony, K. pneumoniae, and
P. aeruginosa, C. albicans). The C. albicans was most sensitive
to SeNPs, with detected MIC values of 25µg/mL for SeNPs-
BSA and SeNPs-Chit, and 72µg/mL for SeNPs-Gluc. When it
comes to bacterial strains, it was noticed higher activity against
Gram-positive bacteria for all formulations of SeNPs. Also, it
was shown that the positive surface charge of SeNPs provides
the better antimicrobial activity. Finally, the synergistic effect
of chitosan was more pronounced than the effect of particle
size. All formulations of SeNPs expressed higher antimicrobial
activity, particularly against C. albicans. In addition, cytotoxicity
of SeNPs toward MRC-5 cells was examined and a significant
difference was noticed. Survival of cells after the treatment with
SeNPs increased in the following order: SeNPs-Gluc<SeNPs-
Chit<SeNPs-BSA. Based on the results obtained for stability,
particle size distribution, and cytotoxicity SeNPs stabilized with
BSA were further used for investigations of antibiofilm activity.
This investigation was done on several monomicrobial and
dual-species biofilms, grown from clinical isolates of S. aureus
and C. albicans. SeNPs-BSA displayed significant inhibition on
all biofilms in a dose-dependent manner in comparison with
control samples. The most expressed activity was detected for
biofilms grown from S. aureusATCC 6538 and C. albicansATCC
10231, where inhibition of more than 90% was recorded in a
concentration range as low as 1.6–6.4µg/mL. The mentioned
bacteria strain were additionally used for testing the inhibition
of dual-species biofilm formation on polystyrene surface of
96-well microtiter plates and radiopaque polyurethane Central
Venous Catheter (CVC). Similar to monomicrobial biofilm,
here it was also detected inhibition of 80% within the same
concentration range. Findings presented in this study will
contribute to a better understanding in the field of SeNPs design
and evaluation, particularly the influence of surface chemistry
on the antimicrobial activity as well as in the activity of SeNPs
against dual-species biofilm grown from clinical isolates.
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